Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.

Prevalence of PH in MPNs is poorly understood with estimates ranging from 3.8% to 58%. Patients with MF and longer duration of disease seem at particularly high risk and should be carefully monitored for PH.